Skip to main content
Erschienen in: Endocrine 2/2024

04.01.2024 | Original Article

Clinical prediction models for cervical lymph node metastasis of papillary thyroid carcinoma

verfasst von: Shuli Luo, Fenghua Lai, Ruiming Liang, Bin Li, Yufei He, Wenke Chen, Jiayuan Zhang, Xuyang Li, Tianyi Xu, Yingtong Hou, Yihao Liu, Jianyan Long, Zheng Yang, Xinwen Chen

Erschienen in: Endocrine | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Accurate preoperative diagnosis of lymph node metastasis (LNM) in papillary thyroid carcinoma (PTC) remains an unsolved problem. This study aimed to construct a nomogram and scoring system for predicting LNM based on the clinical characteristics of patients with PTC.

Methods

1400 patients with PTC who underwent thyroidectomy and lymph node dissection at the First Affiliated Hospital of Sun Yat-sen University were retrospectively enrolled and randomly divided into training and internal testing sets. Furthermore, 692 patients with PTC from three other medical centers were collected as external testing sets. Least absolute shrinkage and selection operator (LASSO) was used to screen the predictors, and a nomogram was constructed. In addition, a scoring system was constructed using 10-fold cross-validation. The performances of the two models were verified among datasets and compared with preoperative ultrasound (US).

Results

Six independent predictors were included in the multivariate logistic model: age, sex, US diagnosis of LNM, tumor diameter, location, and thyroid peroxidase antibody level. The areas under the receiver operating characteristic curve (AUROC) (95% confidence interval) of this nomogram in the training, internal testing, and three external testing sets were 0.816 (0.791–0.840), 0.782 (0.727–0.837), 0.759 (0.699–0.819), 0.749 (0.667–0.831), and 0.777 (0.726–0.828), respectively. The AUROC of the scoring system were 0.810 (0.785–0.835), 0.772 (0.718–0.826), 0.736 (0.675–0.798), 0.717 (0.635–0.799) and 0.756 (0.704–0.808), respectively. The prediction performances were both significantly superior to those of preoperative US (P < 0.001).

Conclusion

The nomogram and scoring system performed well in different datasets and significantly improved the preoperative prediction of LNM than US alone.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat M. Pizzato, M. Li, J. Vignat et al. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol. 10(4), 264–272 (2022)CrossRefPubMed M. Pizzato, M. Li, J. Vignat et al. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol. 10(4), 264–272 (2022)CrossRefPubMed
2.
Zurück zum Zitat M. Brassard, I. Borget, A. Edet-Sanson et al. Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients. J. Clin. Endocrinol. Metab. 96(5), 1352–1359 (2011)CrossRefPubMed M. Brassard, I. Borget, A. Edet-Sanson et al. Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients. J. Clin. Endocrinol. Metab. 96(5), 1352–1359 (2011)CrossRefPubMed
3.
Zurück zum Zitat J.A. Pereira, J. Jimeno, J. Miquel et al. Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery 138(6), 1095–1100 (2005)CrossRefPubMed J.A. Pereira, J. Jimeno, J. Miquel et al. Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery 138(6), 1095–1100 (2005)CrossRefPubMed
4.
Zurück zum Zitat C. Gambardella, E. Tartaglia, A. Nunziata et al. Clinical significance of prophylactic central compartment neck dissection in the treatment of clinically node-negative papillary thyroid cancer patients. World J. Surg. Oncol. 14(1), 247 (2016)CrossRefPubMedPubMedCentral C. Gambardella, E. Tartaglia, A. Nunziata et al. Clinical significance of prophylactic central compartment neck dissection in the treatment of clinically node-negative papillary thyroid cancer patients. World J. Surg. Oncol. 14(1), 247 (2016)CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat H.S. Hwang, L.A. Orloff, Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis from thyroid cancer. Laryngoscope 121(3), 487–491 (2011)CrossRefPubMed H.S. Hwang, L.A. Orloff, Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis from thyroid cancer. Laryngoscope 121(3), 487–491 (2011)CrossRefPubMed
6.
Zurück zum Zitat D.W. Lee, Y.B. Ji, E.S. Sung et al. Roles of ultrasonography and computed tomography in the surgical management of cervical lymph node metastases in papillary thyroid carcinoma. Eur. J. Surg. Oncol. 39(2), 191–196 (2013)CrossRefPubMed D.W. Lee, Y.B. Ji, E.S. Sung et al. Roles of ultrasonography and computed tomography in the surgical management of cervical lymph node metastases in papillary thyroid carcinoma. Eur. J. Surg. Oncol. 39(2), 191–196 (2013)CrossRefPubMed
7.
Zurück zum Zitat K.J. Lee, Y.J. Cho, S.J. Kim et al. Analysis of the clinicopathologic features of papillary thyroid microcarcinoma based on 7-mm tumor size. World J. Surg. 35(2), 318–323 (2011)CrossRefPubMed K.J. Lee, Y.J. Cho, S.J. Kim et al. Analysis of the clinicopathologic features of papillary thyroid microcarcinoma based on 7-mm tumor size. World J. Surg. 35(2), 318–323 (2011)CrossRefPubMed
8.
Zurück zum Zitat C. Liu, C. Xiao, J. Chen et al. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients. BMC Cancer 19(1), 622 (2019)CrossRefPubMedPubMedCentral C. Liu, C. Xiao, J. Chen et al. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients. BMC Cancer 19(1), 622 (2019)CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat B.R. Haugen, E.K. Alexander, K.C. Bible et al. 2015 american thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1), 1–133 (2016)CrossRefPubMedPubMedCentral B.R. Haugen, E.K. Alexander, K.C. Bible et al. 2015 american thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1), 1–133 (2016)CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat S. Lai, Y. Fan, Y. Zhu et al. Machine learning-based dynamic prediction of lateral lymph node metastasis in patients with papillary thyroid cancer. Front. Endocrinol. (Lausanne) 13, 1019037 (2022)CrossRefPubMed S. Lai, Y. Fan, Y. Zhu et al. Machine learning-based dynamic prediction of lateral lymph node metastasis in patients with papillary thyroid cancer. Front. Endocrinol. (Lausanne) 13, 1019037 (2022)CrossRefPubMed
11.
Zurück zum Zitat Q. Hu, W.J. Zhang, L. Liang et al. Establishing a predictive nomogram for cervical lymph node metastasis in patients with papillary thyroid carcinoma. Front. Oncol. 11, 766650 (2021)CrossRefPubMed Q. Hu, W.J. Zhang, L. Liang et al. Establishing a predictive nomogram for cervical lymph node metastasis in patients with papillary thyroid carcinoma. Front. Oncol. 11, 766650 (2021)CrossRefPubMed
12.
Zurück zum Zitat J. Mao, Q. Zhang, H. Zhang et al. Risk factors for lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis. Front. Endocrinol. (Lausanne) 11, 265 (2020)CrossRefPubMed J. Mao, Q. Zhang, H. Zhang et al. Risk factors for lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis. Front. Endocrinol. (Lausanne) 11, 265 (2020)CrossRefPubMed
13.
Zurück zum Zitat E. Xia, Y. Chi, L. Jin et al. Preoperative prediction of lymph node metastasis in patients with papillary thyroid carcinoma by an artificial intelligence algorithm. Am. J. Transl. Res. 13(7), 7695–7704 (2021)PubMedPubMedCentral E. Xia, Y. Chi, L. Jin et al. Preoperative prediction of lymph node metastasis in patients with papillary thyroid carcinoma by an artificial intelligence algorithm. Am. J. Transl. Res. 13(7), 7695–7704 (2021)PubMedPubMedCentral
14.
Zurück zum Zitat R. Rahbari, L. Zhang, E. Kebebew, Thyroid cancer gender disparity. Future Oncol. 6(11), 1771–1779 (2010)CrossRefPubMed R. Rahbari, L. Zhang, E. Kebebew, Thyroid cancer gender disparity. Future Oncol. 6(11), 1771–1779 (2010)CrossRefPubMed
15.
Zurück zum Zitat M. Peng, G. Wei, Y. Zhang et al. Single-cell transcriptomic landscape reveals the differences in cell differentiation and immune microenvironment of papillary thyroid carcinoma between genders. Cell Biosci. 11(1), 39 (2021)CrossRefPubMedPubMedCentral M. Peng, G. Wei, Y. Zhang et al. Single-cell transcriptomic landscape reveals the differences in cell differentiation and immune microenvironment of papillary thyroid carcinoma between genders. Cell Biosci. 11(1), 39 (2021)CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat X. Li, H. Zhang, Y. Zhou et al. Risk factors for central lymph node metastasis in the cervical region in papillary thyroid carcinoma: a retrospective study. World J. Surg. Oncol. 19(1), 138 (2021)CrossRefPubMedPubMedCentral X. Li, H. Zhang, Y. Zhou et al. Risk factors for central lymph node metastasis in the cervical region in papillary thyroid carcinoma: a retrospective study. World J. Surg. Oncol. 19(1), 138 (2021)CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat J. Yu, Y. Deng, T. Liu et al. Lymph node metastasis prediction of papillary thyroid carcinoma based on transfer learning radiomics. Nat. Commun. 11(1), 4807 (2020)CrossRefPubMedPubMedCentral J. Yu, Y. Deng, T. Liu et al. Lymph node metastasis prediction of papillary thyroid carcinoma based on transfer learning radiomics. Nat. Commun. 11(1), 4807 (2020)CrossRefPubMedPubMedCentral
18.
19.
Zurück zum Zitat W. Wang, X. Su, K. He et al. Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: an updated study with more than 2000 consecutive patients. Cancer 122(2), 198–206 (2016)CrossRefPubMed W. Wang, X. Su, K. He et al. Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: an updated study with more than 2000 consecutive patients. Cancer 122(2), 198–206 (2016)CrossRefPubMed
20.
Zurück zum Zitat A.A. Afif, B.A. Williams, M.H. Rigby et al. Multifocal papillary thyroid cancer increases the risk of central lymph node metastasis. Thyroid 25(9), 1008–1012 (2015)CrossRefPubMed A.A. Afif, B.A. Williams, M.H. Rigby et al. Multifocal papillary thyroid cancer increases the risk of central lymph node metastasis. Thyroid 25(9), 1008–1012 (2015)CrossRefPubMed
21.
Zurück zum Zitat H.J. Kim, S.Y. Sohn, H.W. Jang et al. Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma. World J. Surg. 37(2), 376–384 (2013)CrossRefPubMed H.J. Kim, S.Y. Sohn, H.W. Jang et al. Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma. World J. Surg. 37(2), 376–384 (2013)CrossRefPubMed
22.
Zurück zum Zitat K.C. Loh, F.S. Greenspan, F. Dong et al. Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 84(2), 458–463 (1999)CrossRefPubMed K.C. Loh, F.S. Greenspan, F. Dong et al. Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 84(2), 458–463 (1999)CrossRefPubMed
23.
Zurück zum Zitat X. Li, H.W. Zhang, Y. Zhou et al. Risk factors for central lymph node metastasis in the cervical region in papillary thyroid carcinoma: a retrospective study. World J. Surg. Oncol. 19(1), 138 (2021)CrossRefPubMedPubMedCentral X. Li, H.W. Zhang, Y. Zhou et al. Risk factors for central lymph node metastasis in the cervical region in papillary thyroid carcinoma: a retrospective study. World J. Surg. Oncol. 19(1), 138 (2021)CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Y. Wang, J. Zheng, X. Hu et al. A retrospective study of papillary thyroid carcinoma: Hashimoto’s thyroiditis as a protective biomarker for lymph node metastasis. Eur. J. Surg. Oncol. 49(3), 560–567 (2023)CrossRefPubMed Y. Wang, J. Zheng, X. Hu et al. A retrospective study of papillary thyroid carcinoma: Hashimoto’s thyroiditis as a protective biomarker for lymph node metastasis. Eur. J. Surg. Oncol. 49(3), 560–567 (2023)CrossRefPubMed
25.
Zurück zum Zitat W. Wang, L. Wen, S. Chen et al. Preoperative thyroid peroxidase antibody predicts recurrence in papillary thyroid carcinoma: a consecutive study with 5,770 cases. Front. Oncol. 12, 881024 (2022)CrossRefPubMedPubMedCentral W. Wang, L. Wen, S. Chen et al. Preoperative thyroid peroxidase antibody predicts recurrence in papillary thyroid carcinoma: a consecutive study with 5,770 cases. Front. Oncol. 12, 881024 (2022)CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Chinese Society of Endocrinology, Thyroid and Metabolism Surgery Group of the Chinese Society of Surgery, Chinese Society of Nuclear Medicine, et al. Guidelines for the diagnosis and management of thyroid nodules and differentiated thyroid cancer (Second edition). Chin J Endocrinol Metab, 2023, 39(3): 181-226. (In Chinese) Chinese Society of Endocrinology, Thyroid and Metabolism Surgery Group of the Chinese Society of Surgery, Chinese Society of Nuclear Medicine, et al. Guidelines for the diagnosis and management of thyroid nodules and differentiated thyroid cancer (Second edition). Chin J Endocrinol Metab, 2023, 39(3): 181-226. (In Chinese)
Metadaten
Titel
Clinical prediction models for cervical lymph node metastasis of papillary thyroid carcinoma
verfasst von
Shuli Luo
Fenghua Lai
Ruiming Liang
Bin Li
Yufei He
Wenke Chen
Jiayuan Zhang
Xuyang Li
Tianyi Xu
Yingtong Hou
Yihao Liu
Jianyan Long
Zheng Yang
Xinwen Chen
Publikationsdatum
04.01.2024
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2024
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-023-03632-z

Weitere Artikel der Ausgabe 2/2024

Endocrine 2/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.